The story behind the launch of high-throughput screening at Sygnature Discovery

19 February 2020

In this workshop presentation, Denise Swift, senior scientist at Sygnature Discovery, discusses how high-throughput screening (HTS) was established at Sygnature Discovery in Nottingham, U.K.,  with the support of Titian Mosaic, HighRes Biosolutions and Genedata.  HTS was introduced to complement its existing suite of hit-finding approaches and offer a more comprehensive integrated hit-discovery platform to enhance successful early drug discovery for their clients.